2μg (R: reducing condition, N: non-reducing condition).
Product Details
Product Details
Product Specification
| Species | Human |
| Accession | Q8NBP7 |
| Amino Acid Sequence | Gln 31 - Gln 692 with His Tag at the C-Terminus |
| Expression System | HEK293 |
| Molecular Weight | 15-25kDa&55-70kDa (Reducing) |
| Purity | >95% by SDS-PAGE&HPLC |
| Conjugation | Unconjugated |
| Physical Appearance | Lyophilized Powder |
| Storage Buffer | PBS, pH7.4, 5% trehalose |
| Reference | 1. Zhao, M., et al. (2025). PCSK9 with a gain of function D374Y mutation aggravates atherosclerosis by inhibiting PPARα expression. Scientific Reports, 15, 6941. |
Picture
Picture
SDS-PAGE
SEC-HPLC
The purity of PCSK9 His Tag(D374Y) Protein, Human is more than 95% determined by SEC-HPLC.
ELISA
Immobilized Human LDL R, Fc Tag at 2μg/mL (100 μL/well) can bind PCSK9 His Tag(D374Y) Protein, Human (Cat.No.UA016063) with a linear range of 38-76 ng/mL.
